[1] 吴冠青,孙燕.恶性肿瘤的个性化治疗[J].癌症进展,2008,6(6):562-578.
[2] CARNEY K. Personalized medicine[J]. Journal of the California Dental Association,2003,4(6):548-558.
[3] GRIFFITH L G, SWARTZ M A. Capturing complex 3D tissue physiology in vitro[J]. Nature Reviews Molecular Cell Biology,2006,7(3):211-224.
[4] RICHMOND A, SU Y. Mouse xenograft models vs GEM models for human cancer therapeutics[J]. Disease Models & Mechanisms,2008,1(2/3):78-82.
[5] GARNETT M J, EDELMAN E J, HEIDORN S J, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells[J]. Nature,2012,483(7391):570-575.
[6] SHOEMAKER R H. The NCI60 human tumour cell line anticancer drug screen[J]. Nature Reviews Cancer,2006,6(10):813-823.
[7] HEISER L M, WANG N J, TALCOTT C L, et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways[J]. Genome Biology,2009,10(3):31.
[8] KUTALIK Z, BECKMANN J S, BERGMANN S. A modular approach for integrative analysis of largescale geneexpression and drugresponse data[J]. Nature Biotechnology,2008,26(5):531-539.
[9] KANDELA I, ZERVANTONAKIS I. Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data[J]. Science Translational Medicine,2011,3(96):9677-9687.
[1]徐慧,贺平安.基于矩阵填充算法的抗癌药物敏感性预测[J].浙江理工大学学报,2020,43-44(自科二):277.
XU Hui,HE Pingan.Prediction of anticancer drug sensitivity based on matrix completion algorithm[J].Journal of Zhejiang Sci-Tech University,2020,43-44(自科6):277.